MedTrace Logo

Inhibition Effects of Probiotics on Pathogens Associated With VAP

NCT02928042 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2018-01-18

No results posted yet for this study

Summary

This study evaluates that P. aeruginosa, A. baumannii, K. pneumonia and Staph aureus which are obtained from patients' tracheal aspiration culture who treated with mechanical ventilation will be compared with Lactobacillus (LAB) members and nisin bactriocin in the laboratory. The aim is to investigate the probiotics' antimicrobial properties and effects on these bacteria's growth rate.

Conditions

  • Ventilator Associated Pneumonia

Interventions

OTHER

Lactobacillus bacteria

Antimicrobial effects of Lactobacillus bacteria (LAB) and nisin bacteriocin on pathogen bacteria and commercial strains of the same bacteria's growth rate will be investigated.

Sponsors & Collaborators

  • Dilek Özcengiz

    collaborator UNKNOWN

  • Cukurova University

    lead OTHER

Principal Investigators

  • Dilek Özcengiz, Professor · Cukurova University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2018-01-31
Completion
2018-01-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02928042 on ClinicalTrials.gov